UCB SA (UCB-BT)

QUOTE AND NEWS
newratings.com  Jul 7  Comment 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and UCB announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration for romosozumab, an investigational monoclonal antibody for the treatment of osteoporosis in...
The Hindu Business Line  Jun 3  Comment 
Drug firm Jubilant Life Sciences has received final approval from the US health regulator for generic Levetiracetam injection, used for treatment of epilepsy, in the American market. The company h...
MedPage Today  May 23  Comment 
(MedPage Today) -- Superior clinical response, lower disease activity
The Economic Times  Mar 24  Comment 
Top global sports goods players, Nike, Reebok and Adidas, are still in the red in India even as brands like Levis, UCB and Zara have turned profitable.
newratings.com  Mar 21  Comment 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and UCB announced that the BRIDGE study met the primary endpoint, demonstrating a statistically significant increase in bone mineral density at the lumbar spine in men with osteoporosis treated with...
GenEng News  Feb 26  Comment 
UCB has terminated its nearly 10-year-old collaboration with Immunomedics to develop and commercialize the latter’s lead candidate epratuzumab for all non-cancer indications worldwide. No reason for the termination was disclosed by Immunomedics...
newratings.com  Feb 22  Comment 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and UCB announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis or FRAME. These data showed FRAME met the co-primary endpoints by reducing the...





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki